Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive Disorder

NCT07703722 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder
Post-Traumatic Stress Disorder (PTSD)

Interventions

DRUG: Psilocybin
BEHAVIORAL: Structured Integrated Reframing Therapy (SIRT)
DRUG: Selective Serotonin Reuptake Inhibitor (SSRI)

Sponsor

Khyber Medical University Peshawar

Collaborators

[object Object]
[object Object]